Literature DB >> 11292993

Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (Orgalutran/Antagon) to prevent a premature LH surge: a case report.

D De Jong1, E G Van Hooren, N S Macklon, B M Mannaerts, B C Fauser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11292993      PMCID： PMC3455808          DOI： 10.1023/a:1026498629324

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN： 1058-0468            Impact factor:   3.412


× No keyword cloud information.
  17 in total

1.  Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization.

Authors:  Y Gonen; H Balakier; W Powell; R F Casper
Journal:  J Clin Endocrinol Metab       Date:  1990-10       Impact factor: 5.958

2.  The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women.

Authors:  E C Ditkoff; D L Cassidenti; R J Paulson; M V Sauer; W L Paul; J Rivier; S S Yen; R A Lobo
Journal:  Am J Obstet Gynecol       Date:  1991-12       Impact factor: 8.661

3.  Time to revolutionize ovarian stimulation.

Authors:  R G Edwards; R Lobo; P Bouchard
Journal:  Hum Reprod       Date:  1996-05       Impact factor: 6.918

4.  A novel regimen of gonadotropin-releasing hormone (GnRH) antagonist plus pulsatile GnRH: controlled restoration of gonadotropin secretion and ovulation induction.

Authors:  K Gordon; R F Williams; D R Danforth; G D Hodgen
Journal:  Fertil Steril       Date:  1990-12       Impact factor: 7.329

5.  Endogenous LH surge versus hCG as ovulation trigger after low-dose highly purified FSH in IUI: a comparison of 761 cycles.

Authors:  A Romeu; A Monzó; T Peiró; E Diez; J A Peinado; L A Quintero
Journal:  J Assist Reprod Genet       Date:  1997-10       Impact factor: 3.412

6.  Triggering of ovulation by a gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with a GnRH antagonist.

Authors:  F Olivennes; R Fanchin; P Bouchard; J Taieb; R Frydman
Journal:  Fertil Steril       Date:  1996-07       Impact factor: 7.329

7.  Hormonal dynamics at midcycle: a reevaluation.

Authors:  J D Hoff; M E Quigley; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1983-10       Impact factor: 5.958

8.  The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg.

Authors:  F Olivennes; S Alvarez; P Bouchard; R Fanchin; J Salat-Baroux; R Frydman
Journal:  Hum Reprod       Date:  1998-09       Impact factor: 6.918

9.  Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist.

Authors:  J Itskovitz; R Boldes; J Levron; Y Erlik; L Kahana; J M Brandes
Journal:  Fertil Steril       Date:  1991-08       Impact factor: 7.329

10.  Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix).

Authors:  L R Nelson; V Y Fujimoto; R B Jaffe; S E Monroe
Journal:  Fertil Steril       Date:  1995-05       Impact factor: 7.329
View more
  5 in total

Review 1.  Clinical cases in oncofertility.

Authors:  Laxmi A Kondapalli; Fanzhen Hong; Clarisa R Gracia
Journal:  Cancer Treat Res       Date:  2010

2.  The mechanism responsible for the supraphysiologic gonadotropin surge in females treated with gonadotropin-releasing hormone (GnRH) agonist and primed with GnRH antagonist.

Authors:  Joelle E Taylor; Bradley T Miller; Karen D Gray; Richard T Scott; William H Catherino; James H Segars
Journal:  Fertil Steril       Date:  2009-02-06       Impact factor: 7.329

3.  Empty Follicle Syndrome: The Possible Cause of Occurrence.

Authors:  Tahereh Madani; Nadia Jahangiri
Journal:  Oman Med J       Date:  2015-11

4.  Generation of cynomolgus monkey fetuses with intracytoplasmic sperm injection based on the MII-stage oocytes acquired by personalized superovulation protocol.

Authors:  Zhangqiong Huang; Yun Li; Qinfang Jiang; Yixuan Wang; Kaili Ma; Qihan Li
Journal:  J Vet Sci       Date:  2020-05       Impact factor: 1.672

5.  Empty follicle syndrome.

Authors:  Jee Hyun Kim; Byung Chul Jee
Journal:  Clin Exp Reprod Med       Date:  2012-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.